Sonic Healthcare Limited (ASX:SHL)

Market Cap	10.35B -22.3%
Revenue (ttm)	10.42B +11.7%
Net Income	539.40M -1.1%
EPS	1.11 -2.7%
Shares Out	494.08M
PE Ratio	18.94
Forward PE	16.29
Dividend	1.07 (5.05%)
Ex-Dividend Date	Mar 4, 2026

Volume	1,443,352
Average Volume	1,537,458
Open	20.94
Previous Close	20.94
Day's Range	20.58 - 21.02
52-Week Range	20.50 - 29.24
Beta	0.54
RSI	32.80
Earnings Date	May 19, 2026

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1934
• Employees: 45,000
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: SHL

Financial Performance

In fiscal year 2025, Sonic Healthcare's revenue was 9.65 billion, an increase of 7.56% compared to the previous year's 8.97 billion. Earnings were 513.60 million, an increase of 0.49%.